Registration and market entry
NMPA administers national systems for drug and medical-device registration and the corresponding regulatory arrangements for cosmetics.
01Position in the system
A product-lifecycle regulator for medicines, devices and cosmetics
NMPA's work extends from classification, standards and pre-market registration to manufacturing quality, inspection and post-market risk management. Provincial drug regulators and specialist review bodies perform important parts of that system, so the correct route depends on the product and regulatory task.
What it doesRegulates registration and safety of drugs, medical devices and cosmetics, applicable quality systems, inspections and post-market risk management.
When it mattersRelevant to drug and device registration, clinical and manufacturing compliance, cosmetics regulation, recalls, adverse events and life-sciences market access.
02Jurisdiction
What falls within this authority’s remit
Identify the product category and lifecycle stage first: registration, clinical development, manufacturing, distribution and adverse-event work follow different regulatory routes.
Standards and quality systems
Its responsibilities include product standards and good-practice systems covering laboratory, clinical, manufacturing and relevant distribution activities.
Post-market safety
Monitoring and handling adverse reactions or events, inspections, recalls and emergency risk response continue after market entry.
•Official service routes
Match the task to the official service
Use the route that corresponds to the filing, inquiry or administrative service you need.
Official website
Regulates registration and safety of drugs, medical devices and cosmetics, applicable quality systems, inspections and post-market risk management.
Open official service03Official resources
Rules, services and official notices
Start with primary institutional sources. Verify service links and procedural status before relying on a filing path.
05Related legal concepts
Build the vocabulary around your research
Short, practical definitions for concepts most likely to appear alongside this institution.
01
Research tag
drug registration
The review and approval process through which a drug obtains the required authorization for the Chinese market.
02
Research tag
medical device
A regulated instrument, apparatus, material or related product classified according to risk and intended medical use.
03
Research tag
cosmetics
Products applied to the human body for cleansing, protection or beautification, subject to category-specific registration or filing controls.
04
Research tag
GMP
Good Manufacturing Practice requirements governing controlled and documented production capable of consistently meeting quality standards.
05
Research tag
adverse event
An unfavorable occurrence associated with use of a regulated product that may trigger monitoring, evaluation, reporting or corrective action.
06Primary sources
How this entry was source-reviewed
The review date describes when the listed primary sources were checked. It is not a guarantee that jurisdiction remains unchanged after that date.
National Medical Products AdministrationDrug, medical-device and cosmetic registration and lifecycle resources
Open source
Mandate / institutional sourceOfficial description of NMPA product-safety and market-supervision functions
Open source
Reference boundary
This page is a research starting point.
Classify the drug, device or cosmetic, responsible registrant, lifecycle stage and intended claim before checking registration, production, distribution and post-market duties.